| PPV | pneumococcal polysaccharide vaccine; porcine parvovirus; positive predictive value; positive pressur... |
|---|---|
| PV | pancreatic vein; papillomavirus; paraventricular; paravertebral; pemphigus vulgaris; peripheral vasc... |
| RVV | right ventricular volume; rubella vaccine-like virus; Russell viper venom |
| TV | talipes varus; television; tetrazolium violet; thoracic vertebra; tickborne virus; tidal volume; tot... |
| ALV | Abelson leukemia virus; adeno-like virus; alveolar, alveolus; ascending lumbar vein; avian leukosis ... |
| GBV-C/HGV | GB Virus C/Hepatitis G Virus |
|---|---|
| HTLV-III/LAV | human T cell lymphotropic virus type III/lymphadenopathy associated virus |
| HTLV-III/LAV | human T lymphotrophic virus type III/lymphadenopathy-associated virus |
| SV40 | 2-simian virus 40 |
| CIV | 6--Chilo iridescent virus |
| MMR vaccine | <drug> The mumps, measles and rubella vaccine is recommended in all infants. Typically given twice, 15 months and at 4-6 years. (27 Sep 1997) |
|---|---|
| plague vaccine | A suspension of killed yersinia pestis used for immunizing people in enzootic plague areas. (12 Dec 1998) |
| whooping-cough vaccine | See: diphtheria toxoid, tetanus toxoid, and pertussis vaccine. (05 Mar 2000) |
| multivalent vaccine | A vaccine prepared from cultures of two or more strains of the same species or microorganism. Synonym: multivalent vaccine. (05 Mar 2000) |
| mumps vaccine | A live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had mumps or been immunised with live mumps vaccine. Children are usually immunised with measles-mumps-rubella combinatiom vaccine. (12 Dec 1998) |
| pneumococcal vaccine | Vaccine comprised of purified capsular polysaccharide antigen from 23 types of Streptococcus pneumoniae (representing those types responsible for most of the reported pneumococcal diseases in the U.S.). (05 Mar 2000) |
| poliovirus vaccine | A suspension of formalin-inactivated poliovirus, types I, II, and III, grown in monkey kidney cell tissue culture, used in the united states only for immunization of immunologically deficient patients and for primary immunization of unimmunised adults at risk. (12 Dec 1998) |
| poliovirus vaccine, oral | A live vaccine containing attenuated poliovirus, types I, II, and III, grown in monkey kidney cell tissue culture, used for routine immunization of children against polio. This vaccine induces long-lasting intestinal and humoral immunity. Killed vaccine induces only humoral immunity. Oral poliovirus vaccine should not be administered to immunocompromised individuals or their household contacts. (12 Dec 1998) |
| polyvalent vaccine | A vaccine prepared from cultures of two or more strains of the same species or microorganism. Synonym: multivalent vaccine. (05 Mar 2000) |
| crystal violet vaccine | See: hog cholera vaccines. (05 Mar 2000) |
| Haemophilus influenza b vaccine | <virology> A vaccination that is given to infants to protect against infection with haemophilus influenza b, an important cause of neonatal sepsis. Typically administered at 2, 4, 6 and 15 months. Children who are aged 15 months to 5 years, who have not received the vaccine, should be given a single injection of haemophilus b conjugate vaccine. Acronym: HIB (26 Mar 1998) |
| Haemophilus influenzae type B vaccine | A conjugate of oligosaccharides of the capsular antigen of H. Influenzae type B and diphtheria CRM protein. (05 Mar 2000) |
| Haffkine's vaccine | A killed culture of Vibrio cholerae in two strengths, a weaker one for the initial inoculation and a stronger one for the second inoculation 7 to 10 days after the first, a killed plague bacillus (Yersinia pestis) vaccine. (05 Mar 2000) |
| sabin vaccine | Oral Polio virus Vaccine (OPV). The polio virus in opv is attenuated (weakened). The sabin vaccine is named after the american virologist albert sabin. See immunization, polio. (12 Dec 1998) |
| salk vaccine | Inactivated Polio Vaccine (IPV). The polio virus in ipv has been inactivated (killed). The salk vaccine is named after the american physician-virologist jonas salk. See immunization, polio. (12 Dec 1998) |